Telethon Foundation Announces Positive CHMP Opinion for Waskyra™ Gene Therapy for WAS The Telethon Foundation has received a positive CHMP recommendation for Waskyra™, a gene therapy designed to treat Wiskott-Aldrich syndrome (WAS), offering hope to affected patients.

Telethon Foundation Announces Positive CHMP Opinion for Waskyra™ Gene Therapy for WAS #Italy #Milan #Waskyra™ #Wiskott-Aldrich #Telethon_Foundation

Telethon Foundation Receives Positive CHMP Opinion for Waskyra Gene Therapy to Combat Wiskott-Aldrich Syndrome The Telethon Foundation has announced a positive opinion from CHMP for Waskyra™, a gene therapy aimed at treating Wiskott-Aldrich Syndrome, a rare primary immunodeficiency disorder.

Telethon Foundation Receives Positive CHMP Opinion for Waskyra Gene Therapy to Combat Wiskott-Aldrich Syndrome #Italy #Rome #Wiskott-Aldrich #Waskyra #Telethon_Foundation